Search results
Results from the WOW.Com Content Network
Given that the stock is currently trading at 22.8 times William Blair’s 2025 EPS estimate of $5.16, the analyst maintains an Outperform rating on Abbott. Abbott Laboratories Stock Prediction For ...
Health care company Abbott Laboratories (NYSE: ABT ) has had a strong start to the year with forecast-beating first-quarter results and in-line full-year guidance. The Analyst Raymond James ...
Abbott Laboratories is also an excellent dividend stock, currently on a streak of 52 consecutive payout increases. If you opt to reinvest the dividend -- currently yielding 1.8% -- you'll see ...
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, in the United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Abbott Laboratories wasn’t one of them. The 10 stocks that ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Here is how Abbott (ABT) and Organogenesis (ORGO) have performed compared to their sector so far this year.